Clasificación en acciones
#41229
GENinCode Plc specializes in the creation and commercialization of advanced... GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
Precio por acción
$0.01206398
Capitalización bursátil
$33.74K
Comercio GENinCode plc (GENI)
Número de acciones en circulación de GENinCode plc (GENI)
Número de acciones en circulación al August 2026: 0
Según los últimos informes financieros y el precio de las acciones de GENinCode plc, el número actual de acciones en circulación es 0. Al final de August 2026, la empresa tenía 0 acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de GENinCode plc (GENI) desde 2026 hasta 2026
Acciones en circulación al final de cada año
| Año |
Acciones en circulación |
Cambiar |
|
Not enough data for the provided dates. |
Acciones en circulación de empresas similares o competidores
| Empresa |
Acciones en circulación |
Diferencia |
País |
|
|
371.00M |
-
|
US
|
|
|
705.30M |
-
|
US
|
|
|
- |
-
|
CN
|
|
|
80.10M |
-
|
US
|
|
|
143.28M |
-
|
US
|
